Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02133183
Title TORC1/2 Inhibitor INK128 Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
UCSF Medical Center-Parnassus San Francisco California 94143 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field